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Association of neuroinflammation with
episodic memory: a [11C]PBR28 PET study in
cognitively discordant twin pairs
Noora Lindgren,1 Jouni Tuisku,1 Eero Vuoksimaa,2 Semi Helin,1 Mira Karrasch,3
Päivi Marjamäki,1 Jaakko Kaprio2,4 and Juha O. Rinne1,5
Alzheimer’s disease is associated with chronic response of innate immune system, referred as neuroinflammation. PET radioligands
binding to the 18 kDa translocator protein are potential biomarkers of neuroinflammation. Translocator protein PET studies in mild
cognitive impairment and Alzheimer’s disease have indicated controversial results, possibly reflecting interindividual variation and het-
erogeneity of study populations. We controlled for genetic and environmental effects by studying twin pairs discordant for episodic
memory performance. Episodic memory impairment is a well-known cognitive hallmark of early Alzheimer’s disease process. Eleven
same-sex twin pairs (four monozygotic pairs, six female pairs, age 72–77 years) underwent [11C]N-acetyl-N-(2-methoxybenzyl)-2-phe-
noxy-5-pyridinamine ([11C]PBR28) PET imaging, structural magnetic resonance imaging and neuropsychological testing in 2014–17.
Main PET outcome was the volume-weighted average standardized uptake value of cortical regions vulnerable to Alzheimer’s disease
pathology. Ten pairs were discordant for episodic memory performance. In the eight pairs with identical translocator protein geno-
type, twins with poorer episodic memory had 20% higher cortical [11C]PBR28 binding compared with their better-performing co-
twins (mean intra-pair difference 0.21 standardized uptake value, 95% confidence interval 0.05–0.37, P¼ 0.017). The result
remained the same when including all discordant pairs and controlling for translocator protein genotype. Increased translocator pro-
tein PET signal suggests that increased microglial activation is associated with poorer episodic memory performance.
Twins with worse episodic memory performance compared with their co-twins had on average 20% higher uptake of the neuroin-
flammatory marker translocator protein PET tracer 11[11C]PBR28. The findings support a negative association between neuroinflam-
mation and episodic memory and the use of translocator protein positron emission tomography as a useful indicator of Alzheimer’s
disease process.
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Introduction
Increasing evidence indicates that chronic response of in-
nate immune system characterized by reactive glial cells
and elevated levels of inflammatory mediators is a key
player in the development of Alzheimer’s disease from
the early stage (Heppner et al., 2015). Particularly, aber-
rant function of microglial cells has revealed to be critical
in the pathogenesis of Alzheimer’s disease.
The 18-kDa translocator protein (TSPO) is the most
commonly used marker of neuroinflammation in clinical
PET studies. Previous studies using the second-generation
TSPO tracer [11C]N-acetyl-N-(2-methoxybenzyl)-2-phe-
noxy-5-pyridinamine ([11C]PBR28) have shown conflict-
ing results with regard to increased TSPO PET signal as
a marker of early stages of Alzheimer’s disease (Kreisl
et al., 2013; Dani et al., 2018; Fan et al., 2018; Schain
et al., 2018; Femminella et al., 2019). The high interindi-
vidual variance in [11C]PBR28 binding may contribute to
the conflicting results (Collste et al., 2016; Tuisku et al.,
2019).
We aimed to minimize the effect of genetic and envir-
onmental variation by studying the brain uptake of
TSPO tracer [11C]PBR28 in monozygotic and dizygotic
twin pairs discordant for episodic memory (EM) perform-
ance. EM impairment is a well-known cognitive hallmark
of early Alzheimer’s disease process. Our aims were to
determine if increased uptake of [11C]PBR28 is detected
in twins with worse EM performance as compared with
their better-performing co-twins and in twins with amnes-
tic mild cognitive impairment (aMCI) as compared with
their co-twins with age-normative EM performance. In
addition, we investigated within-twin pair differences in
continuous measure of TSPO PET binding in relation to
within-twin pair differences in continuous EM (including
verbal immediate and delayed recall, visual delayed recall
and incidental memory) and global cognitive function
measures.
Materials and methods
Cognitively discordant same-sex twin pairs born in 1938–
44 were recruited from the older Finnish Twin Cohort
study using a telephone interview including the telephone
assessment for dementia and the modified Telephone
Interview for Cognitive Status instruments in 2013–17
(Lindgren et al., 2019). A total of 1110 same-sex twin
pairs were invited to participate in the telephone inter-
view. Cognitively discordant twin pairs based either on
the interview or on a previous diagnosis of Alzheimer’s
disease or memory impairment in one twin sibling were
asked to participate in the brain imaging study. Out of
559 pairs in which both co-twins participated, 39 cogni-
tively discordant pairs were excluded from the brain
imaging study due to neurological and psychiatric disor-
ders other than Alzheimer’s disease or mild cognitive im-
pairment, including history of major stroke or head
trauma, significant medical conditions affecting the ability
to undergo the study or contraindications for MRI and
PET scanning, and 36 discordant pairs were excluded be-
cause one or both co-twins declined permission to contact
or declined to participate in the imaging study. After gen-
otyping for the rs6971 (C/T) polymorphism in the TSPO
gene and excluding 2 twin pairs with TT genotype (low-
affinity binders), 11 twin pairs participated to
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[11C]PBR28 imaging at the Turku PET Centre, Finland,
in 2014–17.
The participants received the mean injection of 492 (SD
21) MBq of [11C]PBR28 with >99.9% radiochemical pur-
ity and the mean molar activity of 293 (SD 104) MBq/
nmol and underwent a 70-min dynamic PET scan using a
High Resolution Research Tomograph (Siemens/CTI,
Knoxville, TN, USA). Twins had PET scans within 1 week
from each other. The details of [11C]PBR28 synthesis, PET
acquisition and preprocessing have been described else-
where (Tuisku et al., 2019). T1-weighted MRI scans were
acquired using a 3-T scanner (Philips Ingenuity TF PET/
MR, Philips Medical Systems, Cleveland, OH, USA). After
applying an automated region of interest generation with
FreeSurfer software (version 6.0.0) and using PET data
from 30 to 70 min after injection, a grey matter (GM)
composite standardized uptake value [SUV, the ratio of tis-
sue radioactivity concentration (kBq/ml) and administered
dose (MBq) divided by body weight (kg)] were calculated
as the volume-weighted average SUV across six region of
interests (prefrontal, parietal, lateral temporal, precuneus,
posterior cingulate and mesial temporal cortex). For 18
twins (7 full pairs) with available metabolite-corrected ar-
terial input function, a GM distribution volume (VT) and a
delivery rate constant (K1) were estimated with two-tissue-
compartment model by using an in-house created software
(http://www.turkupetcentre.net/petanalysis/tpcclib/doc/fitk4.
html, accessed 12 March 2020), where metabolite and
delay-corrected arterial plasma curve were used as an input
function, blood volume fraction was fixed to 5% and the
estimation was weighted by using the frame lengths.
The participants were also administered a neuropsycho-
logical test battery including multiple cognitive measures.
The primary measures of EM that were used in our clas-
sification of discordance were the delayed word list recall
from the Consortium to Establish a Registry for
Alzheimer’s disease Neuropsychological Battery (CERAD-
NB) and Logical Memory delayed recall from the
Wechsler Memory Scale-Revised. The test performances
were transformed into standard deviation (SD) units
based on age-appropriate Finnish norms (Ylikoski, 2000;
Sotaniemi et al., 2012). Ten twin pairs had differing
delayed verbal EM test performance. Following the Jak/
Bondi actuarial neuropsychological criteria, aMCI was
defined by 1 SD or poorer performance in both two
tests (Jak et al., 2009). Based on this approach, we iden-
tified eight twin pairs who fulfilled a more specific and
stringent criteria of discordance for EM. In addition, the
mean of the two SDs constituted a continuous EM score
[e.g. (1.2þ0.9)/2¼1.05], which was used in the
analysis including all 11 twin pairs and using continuous
variables. In addition, other measures of memory per-
formance were used to examine the association between
continuous memory performance and [11C]PBR28 binding
in all twin pairs. The mean of SDs of the delayed visual
reproductions test from the Wechsler Memory Scale-
Revised and the delayed constructional praxis savings
from the CERAD-NB was used to measure delayed visual
EM performance, an independent delayed free recall
measure that was not used in the determination of EM
discordance. The immediate verbal EM performance was
assessed with the mean of SDs of the immediate word
list recall from the CERAD-NB and Logical Memory im-
mediate recall from the Wechsler Memory Scale-Revised.
The free recall score of the Boston Naming test (memo-
BNT) was used to measure incidental memory. In
addition, we examined the association between global
cognitive performance measured with the CERAD total
score (Chandler et al., 2005) and [11C]PBR28 binding.
Zygosity was confirmed by genotyping multiple poly-
morphic markers. The study was approved by the Ethics
Committee of the Hospital District of Southwest Finland
in accordance with the Declaration of Helsinki, and the
written informed consent was obtained from the
participants.
Statistical analysis
In the eight twin pairs with the same TSPO genotype
(five CC; three CT), paired t-test was used to compare
the differences in [11C]PBR28 GM SUV between pairs
discordant for EM or aMCI status (similar results with
Wilcoxon signed-rank tests not shown). When including
additional two twin pairs with differing TSPO genotype,
we used linear conditional fixed effects regression with
TSPO genotype as a covariate (Stata command ‘xtreg’
with the ‘fe’ option). The associations of continuous
memory scores and CERAD total score with the
[11C]PBR28 GM SUV were also tested using linear condi-
tional fixed effects regression with TSPO genotype as a
covariate. Two-tailed P-values <0.05 indicated statistical
significance. The analyses were conducted using Stata
14.2 (Stata Corp., College Station, TX, USA). Voxel-wise
comparisons in 8-mm FWHM-smoothed [11C]PBR28
SUV images between EM discordant twins with the same
TSPO genotype were done using Statistical Non-
Parametric Mapping (version 13) with a paired t-test de-
sign and a cluster defining threshold of P< 0.01 (cor-
rected for family-wise error at significance level P< 0.05).
Data availability
Due to the consent given by study participants and the
high degree of identifiability, data cannot be made public-
ly available. These data may be shared with authorized
researchers, upon researcher’s request, who have IRB/eth-
ics approval and an institutionally approved study plan.
Results
Descriptive statistics
Table 1 shows the characteristics of 11 twin pairs.
Participants’ ages ranged from 72 to 77 years (median¼ 74),
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and the years of education ranged from 6 to 13 years
(median¼ 7), reflecting the low level of formal education in
the post-World War II years in Finland. In eight pairs, the
twins had the same duration of education. Ten twin pairs were
discordant for the primary measure of EM performance. In
these pairs, nine twins with poorer delayed verbal EM per-
formance had also poorer global cognitive performance, inci-
dental memory performance and delayed visual EM
performance as compared with their co-twins. Eight twins
with poorer delayed verbal EM performance had also poorer
immediate verbal EM performance as compared with their co-
twins.
Pairs discordant for episodic
memory
Ten pairs had discordant EM test performance, and eight
pairs were identical for TSPO genotype. Twins with
poorer EM as compared with their co-twins had on aver-
age 20% higher [11C]PBR28 GM binding [intra-pair dif-
ference 0.21 SUV, 95% confidence interval (CI) 0.05–
0.37, P¼ 0.017]. The region of interest and voxel-level
results are displayed in Fig. 1. When including 10 pairs
and controlling for TSPO genotype, co-twins with poorer
EM performance had higher [11C]PBR28 binding in the
GM compared with their better-performing co-twins
(intra-pair difference 0.21 SUV units, 95% CI 0.05–0.37,
P¼ 0.016).
Six twin pairs identical for TSPO genotype had avail-
able VT results. Twins with poorer EM had on average
16% higher [11C]PBR28 GM VT compared with their
better-performing co-twins, but the result did not reach
statistical significance (intra-pair difference 0.58 ml/cm3,
95% CI 0.74 to 1.90, P¼ 0.31). The delivery rate con-
stant (K1) of cortical GM was similar between twins with
poorer EM compared with their better-performing twins
with mean K1 values 0.194 (SD 0.063) and 0.199 (SD
0.037) ml/min/ml, respectively.
Pairs discordant for at least
amnestic mild cognitive
impairment-level impairment
Eight twin pairs were discordant for at least aMCI. In
the six pairs with the same genotype, twins with aMCI
had on average 25% higher [11C]PBR28 GM binding
compared with their healthy siblings (intra-pair difference
0.26 SUV, 95% CI 0.06–0.46, P¼ 0.019). When TSPO
genotype in eight pairs was controlled, twins with aMCI
Table 1 Characteristics and [11C]PBR28 SUVs and VTs
Discordant
for EM
performance
Discordant
for at least
aMCI
Zyg TSPO Verbal
DR
Visual
DR
Verbal
IR
Incidental
memory
CERAD
total
PBR28
GM
SUV
PBR28
cerebellar
SUV
PBR28
GM
VT
PBR28
cerebellar
VT
Pair 1 Twin 1 Control No MZ HAB 1.2 1.1 0.9 13 87 1.01 0.81 2.9 2.3
Twin 2 Case MZ HAB 0.1 1.0 0.5 8 74 1.06 1.00 4.3 3.9
Pair 2 Twin 1 Control Control MZ MAB 0.7 0.7 0.5 4 72 0.78 0.54
Twin 2 Case Case MZ MAB 1.2 0.3 1.1 1 69 0.94 0.75 3.8 3.0
Pair 3 Twin 1 Control Control MZ HAB 1.0 0.6 1.1 4 67 1.37 1.21 4.6 4.0
Twin 2 Case Case MZ HAB 1.2 0.3 0.5 4 68 1.62 1.41 6.3 5.4
Pair 4 Twin 1 Control No MZ MAB 1.2 0.2 1.9 5 75 1.07 0.96 3.2 2.9
Twin 2 Case MZ MAB 0.4 0.4 0.2 3 61 1.11 0.97 3.2 2.8
Pair 5 Twin 1 Control Control DZ HAB 0.3 0.9 0.5 8 85 1.34 1.22 5.4 4.8
Twin 2 Case Case DZ MAB 3.1 1.5 4.1 2 34 0.71 0.58 2.8 2.2
Pair 6 Twin 1 Not discordant DZ HAB 0.5 0.0 0.8 2 67 1.08 1.11 4.7 4.7
Twin 2 DZ HAB 0.5 0.6 0.1 3 77 1.21 1.23
Pair 7 Twin 1 Control Control DZ HAB 2.4 1.3 2.5 8 93 1.14 0.97 5.2 4.3
Twin 2 Case Case DZ HAB 1.6 0.8 1.5 6 65 1.34 1.31 5.3 5.1
Pair 8 Twin 1 Control Control DZ HAB 0.6 0.7 0.8 11 80 0.94 0.94 2.9 2.9
Twin 2 Case Case DZ MAB 1.2 0.6 0.6 8 77 1.02 0.93
Pair 9 Twin 1 Control Control DZ MAB 0.6 0.4 0.2 3 80 0.84 0.87
Twin 2 Case Case DZ MAB 2.8 1.3 2.8 1 49 1.22 1.15 2.7 2.5
Pair 10 Twin 1 Control Control DZ HAB 1.1 1.5 0.8 9 91 0.85 0.84 4.0 3.9
Twin 2 Case Case DZ HAB 2.1 1.4 0.2 1 68 1.41 1.24 5.7 4.8
Pair 11 Twin 1 Control Control DZ HAB 0.9 0.3 1.6 1 69 1.24 1.24 5.7 5.7
Twin 2 Case Case DZ HAB 1.3 0.5 1.6 0 54 1.26 1.34 4.3 4.5
Case refers to the twin with poorer EM performance as compared with the control co-twin. Verbal DR is the average of SD units from the delayed word list recall from the
CERAD-NB and the delayed Logical Memory recall from the WMS-R. aMCI is defined by 1 SD or poorer performance in both verbal DR tests. The visual DR is the average of SD
units from the delayed visual reproductions test from WMS-R and the delayed constructional praxis savings from the CERAD-NB. The verbal IR is the average of SD units from the
immediate word list recall from the CERAD and the immediate Logical Memory recall from the WMS-R. The incidental memory is the free recall score of MEMO-BNT test. PBR28
GM SUV/VT is the volume-weighted average of prefrontal cortex, parietal cortex, lateral temporal cortex, precuneus, posterior cingulate and mesial temporal cortex SUVs or VTs .
DR, delayed recall; DZ, dizygotic; HAB, high-affinity binder (CC genotype); IR, immediate recall; MAB, mixed-affinity binder (CT genotype); MEMO-BNT; Boston Naming Test; MZ,
monozygotic; [11C]PBR28 GM SUV, [11C]PBR28 gray matter standardized uptake value; VT, distribution volume (calculated with two-tissue-compartment model and metabolite-cor-
rected arterial input function); WMS-R, Wechsler Memory Scale-Revised; Zyg, zygosity.
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had higher [11C]PBR28 binding compared with their co-
twins (intra-pair difference 0.26 SUV units, 95% CI
0.07–0.45, P¼ 0.014).
In the four pairs with identical TSPO genotype and
available VT values, twins with aMCI had on average
11% higher [11C]PBR28 GM VT compared with their
better-performing co-twins, but the result did not reach
statistical significance (intra-pair difference 0.54 ml/cm3,
95% CI 1.86 to 2.94, P¼ 0.53).
Analyses with continuous episodic
memory scores
The association between continuous EM score (delayed
verbal recall) and [11C]PBR28 GM binding was examined
within all 11 twin pairs: one SD lower performance was
associated with 0.08 SUV units (95% CI 0.15 to
0.01, P¼ 0.027) higher [11C]PBR28 binding. Next, we
analysed if the within-twin pair differences in other EM
and global cognition measures were related to within-
twin pair differences in [11C]PBR28 binding. There was a
negative visual EM-[11C]PBR28 GM binding association:
one SD lower performance was associated with 0.13 SUV
units (95% CI 0.26 to 0.00, P¼ 0.044) higher
[11C]PBR28 GM binding. There was also a negative inci-
dental memory-[11C]PBR28 GM binding association: one
point lower free recall score from the memo-BNT was
associated with 0.05 SUV units (95% CI 0.09 to 0.00,
P¼ 0.048) higher [11C]PBR28 binding. In contrast, the
associations of immediate verbal EM score (B¼0.03,
95% CI 0.12 to 0.06, P¼ 0.44) and total CERAD
score (B¼ 0.00, 95% CI 0.02 to 0.01, P¼ 0.56) with
[11C]PBR28 GM binding were not found to be statistical-
ly significant.
Discussion
We found that twins with poorer EM had higher
[11C]PBR28 uptake in cortical GM regions compared
with their better-performing co-twins. The increase in
TSPO binding was seen especially in the posterior cingu-
late/precuneus, parietal cortex, temporal cortex and anter-
ior frontal lobe (Fig. 1), i.e. in many areas typically
showing early accumulation of beta-amyloid in
Alzheimer’s disease. Furthermore, twins with at least an
aMCI-level impairment had higher [11C]PBR28 uptake
compared with their intact co-twins. Despite the small
sample size, the differences in [11C]PBR28 SUV values
were statistically significant and showed consistency in re-
gion of interest and voxel-level analyses. [11C]PBR28 VT
values were not available for all twin pairs. Twins with
poorer EM had higher [11C]PBR28 VT, but the difference
was not statistically significant probably due to the lim-
ited sample size. We also detected a statistically signifi-
cant associations between the continuous measures of
delayed verbal EM, delayed visual EM and incidental
memory performance and the [11C]PBR28 SUV. On the
contrary, there were no statistically significant associa-
tions between the immediate verbal EM or global cogni-
tive performance with the [11C]PBR28 SUV.
Figure 1 [11C]PBR28 GM uptake in eight twin pairs discordant for EM performance and concordant for TSPO genotype.
(A) [11C]PBR28 GM SUVs of twins with poorer EM performance (referred as cases) compared with their co-twins stratified into HABs and
MABs. EM discordant twin pairs where case has at least aMCI based on two delayed free recall measures are shown with full lines. The GM
composite SUV is the volume-weighted average of six ROIs including the prefrontal, parietal, lateral temporal, precuneus, posterior cingulate and
mesial temporal cortex. (B) Statistically significant pairwise differences of [11C]PBR28 SUVs in eight discordant twin pairs at the voxel level (the
0.05 family-wise error-corrected widespread bilateral critical cluster size was 119 790). The colour bar represents T-values, in which brighter
colour indicates greater T-values (T¼ 2.998 corresponds to cluster defining threshold of P< 0.01). HABs, high-affinity binders; MABs, mixed-
affinity binders; ROIs, region of interests.
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In previous studies using [11C]PBR28, higher binding
has been detected in Alzheimer’s disease dementia and
MCI (Lyoo et al., 2015; Kreisl et al., 2017; Fan et al.,
2018; Schain et al., 2018), while others have not found
statistically significant group differences compared with
healthy controls (Dani et al., 2018; Femminella et al.,
2019). The negative findings are not explained by smaller
sample sizes. When using absolute quantification, higher
binding was detected only if [11C]PBR28 VT values were
corrected for the free fraction of radioligand in plasma
(Lyoo et al., 2015; Kreisl et al., 2017), whereas in some
cases, there was no statistically significant group differ-
ence in [11C]PBR28 VT between Alzheimer’s disease and
healthy individuals (Dani et al., 2018; Schain et al.,
2018; Femminella et al., 2019). Some studies have
detected higher [11C]PBR28 binding in Alzheimer’s dis-
ease using the SUV ratio method with cerebellar GM as
a pseudo-reference region (Lyoo et al., 2015; Kreisl et al.,
2017). Studies using other second-generation TSPO
ligands than [11C]PBR28 show similar results: most stud-
ies have found higher cortical binding in Alzheimer’s dis-
ease dementia but results on the group differences
between individuals with MCI and healthy controls are
more conflicting (see Supplementary Table 1 for compil-
ation of previous TSPO PET studies).
We used SUV as the primary outcome measure because
arterial input function was not available for all twins.
[11C]PBR28 SUV is moderately associated with VT and
has high test–retest reliability (Nair et al., 2016;
Matheson et al., 2017). SUV has been used to analyse
[11C]PBR28 data, for example in a study that identified a
significant association between the Alzheimer’s disease-
linked PARP1 gene and [11C]PBR28 PET (Kim et al.,
2013). However, the pairwise SUV differences could be
biased by differential peripheral TSPO expression, tracer
metabolism or tracer delivery to tissue. At least intra-pair
differences in cerebral perfusion did not account for those
in [11C]PBR28 SUV because there was no difference in
the available K1 values. In addition, intra-pair differences
in VT, which is independent of perfusion, seemed to sup-
port the SUV results. The quantification of specific bind-
ing of TSPO tracers is challenging as there is no brain
region devoid of specific TSPO binding sites. Cerebellum
has been used as a pseudo-reference region in individuals
with Alzheimer’s disease and in healthy individuals to cal-
culate the SUV ratio of [11C]PBR28 uptake (Lyoo et al.,
2015). We did not apply SUV ratio because twins with
poorer EM performance had higher [11C]PBR28 cerebel-
lar SUVs compared with their co-twins (intra-pair differ-
ence 0.21 SUV, 95% CI 0.11–0.32, P¼ 0.002, n¼ 8
pairs; 0.60 ml/cm3, 95% CI 0.51 to 1.71, P¼ 0.22,
n¼ 6 pairs; Table 1). Some previous studies have also
found higher TSPO PET signal in the cerebellum in
Alzheimer’s disease as compared with healthy controls
(Fan et al., 2018; Bradburn et al., 2019), while others
have not (Lyoo et al., 2015; Schain et al., 2018). Non-in-
vasive quantification of [11C]-R-PK11195 is achieved
with the supervised clustering algorithm, which identifies
a cluster of reference voxels that have kinetic behaviour
resembling that of normal GM. However, it is debatable
whether this procedure is suited for the high-affinity
tracer [11C]PBR28 (Rizzo et al., 2019; Zanotti-Fregonara
et al., 2019).
Another challenge related to TSPO PET imaging is the
unclear cellular nature of TSPO PET signal. Human post-
mortem brain studies indicate that upregulated TSPO re-
sponse originates mainly from microglia in Alzheimer’s
disease, but astrocytes may also contribute (Venneti
et al., 2009). However, TSPO binding sites are also pre-
sent particularly in vascular cells in the CNS (Tomasi
et al., 2008). Upregulated TSPO response may reflect ei-
ther or both protective and detrimental neuroinflamma-
tory processes.
Most previous cross-sectional studies have found that
higher TSPO binding is associated with worse cognitive
performance, which has typically been measured with
Mini-Mental State Examination, while almost as often
studies have not detected a correlation between TSPO
binding and cognitive performance (Supplementary Table
1). On the contrary, the largest TSPO PET studies of
Alzheimer’s disease individuals detected that higher cor-
tical TSPO binding was cross-sectionally associated with
better Mini-Mental State Examination score (Hamelin
et al., 2016, 2018). The first longitudinal results suggest
that increase in cortical TSPO PET signal is associated
with decline in global cognition, function and GM vol-
ume in Alzheimer’s disease (Kreisl et al., 2016; Hamelin
et al., 2018). Fewer studies have examined the association
of TSPO binding particularly with EM performance. One
study found that worse delayed word list recall score was
associated with higher TSPO binding in the precuneus in
Alzheimer’s disease (Passamonti et al., 2018), while two
studies did not find a correlation with delayed verbal EM
test scores (Kreisl et al., 2017; Knezevic et al., 2018).
Our results supported specifically the presence of a
negative relationship between cortical TSPO binding and
the delayed recall measures of EM performance. First,
twin discordance and within-twin pair differences in the
verbal delayed free recall performance were associated
with TSPO binding. Second, there was also a negative as-
sociation between the delayed visual recall, measure that
was not used for the classification of discordance and
TSPO binding. Third, there was no significant association
between the immediate verbal recall or global cognitive
performance and TSPO binding. Delayed recall measures
have been found as more sensitive in the early
Alzheimer’s disease stages in comparison to immediate re-
call measures (Chen et al., 2000; Elias et al., 2000;
Saxton et al., 2004), although not always (Bilgel et al.,
2014). Immediate and delayed recall measures have at
least partly different neural correlates and genetic influen-
ces (Wolk and Dickerson, 2011; Kremen et al., 2014).
EM measures are more sensitive in the early stages of
Alzheimer’s disease than global cognitive screening
6 | BRAIN COMMUNICATIONS 2020: Page 6 of 8 N. Lindgren et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/braincom
m
s/article/2/1/fcaa024/5771314 by guest on 30 O
ctober 2020
measures that typically detect impairment later during the
Alzheimer’s disease continuum (Chen et al., 2000; Bilgel
et al., 2014). Our different results with the immediate
and delayed recall measures of EM and finding no associ-
ation between global cognition and TSPO binding may
support increased neuroinflammation in the context of
early Alzheimer’s disease. However, the small sample size
restricts us from drawing strong conclusions. In addition,
we found a negative association between incidental mem-
ory performance and TSPO binding. Other studies have
indicated that poorer incidental memory differentiates
those with mild Alzheimer’s disease from cognitively nor-
mal individuals (Karrasch et al. 2010; Kontaxopoulou
et al. 2018).
We detected negative cognition–neuroinflammation
associations based on multiple memory tests. However,
our study was cross-sectional and, therefore, it is not pos-
sible to conclude whether neuroinflammation is a primary
pathology that leads to poorer memory performance or a
secondary response to other pathologies. Finally, the
small number of twin pairs did not allow us to analyse
the result separately in monozygotic and dizygotic twin
pairs.
In conclusion, we found in a matched case–control
twin study that increased cortical neuroinflammation
measured with [11C]PBR28 PET was associated with
poorer delayed EM performance.
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